Average Co-Inventor Count = 3.21
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hanall Biopharma Co., Ltd. (9 from 27 patents)
2. Hanall Pharmaceuticals, Co. Ltd (2 from 2 patents)
3. Catalyst Biosciences, Inc. (1 from 26 patents)
4. Hanall Pharmaceutical Company, Ltd. (1 from 2 patents)
5. Nautilus Biotech (1 from 1 patent)
14 patents:
1. 8383388 - Modified coagulation factor IX polypeptides and use thereof for treatment
2. 8252743 - Modified erythropoietin polypeptides and uses thereof for treatment
3. 8222209 - Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof
4. 8114839 - Protease resistant modified erythropoietin polypeptides
5. 8105573 - Protease resistant modified IFN beta polypeptides and their use in treating diseases
6. 8057787 - Protease resistant modified interferon-beta polypeptides
7. 8052964 - Interferon-β mutants with increased anti-proliferative activity
8. 7998930 - Modified growth hormones
9. 7998469 - Protease resistant interferon beta mutants
10. 7884073 - Modified growth hormone
11. 7650243 - Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
12. 7647184 - High throughput directed evolution by rational mutagenesis
13. 7611700 - Protease resistant modified interferon alpha polypeptides
14. 7349812 - Method for determining the titer of biological agents in living target cells